NASDAQ
BioMark Diagnostics Inc. (BMKDF) has a current ratio of 2.14x as of Monday, May 25, 2026. This represents a 446.38% increase compared to its 12-month average of 0.39x. The current ratio measures a company's ability to cover short-term obligations by comparing current assets to current liabilities.
No price data available for this timeframe.